CYTK
CYTOKINETICS INC
NASDAQ · Healthcare · Biotechnology · US
$68.78
−1.63%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$1.45
- Revenue estimate
- $39.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.50
- EPS estimate
- -$1.63
- Revenue actual
- $28.6M
- Revenue estimate
- $17.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +2.4%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $115
- PT range
- $103 – $140
- Analysts
- 9
9 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.63 | -$1.50 | Beat 7.98% | $28.6M |
| May 5, 2026 | -$1.67 | -$1.67 | In line | $19.4M |
| Feb 24, 2026 | -$1.48 | -$1.50 | Miss -1.35% | $17.8M |
| Nov 5, 2025 | -$1.59 | -$1.54 | Beat 3.14% | $1.9M |
| Aug 7, 2025 | -$1.34 | -$1.12 | Beat 16.42% | $66.8M |
| Feb 27, 2025 | -$1.29 | -$1.26 | Beat 2.33% | $16.9M |
| Feb 27, 2024 | -$1.03 | -$1.38 | Miss -33.98% | $1.7M |
| Nov 2, 2023 | -$0.72 | -$1.35 | Miss -87.50% | $378.0K |
| Aug 3, 2023 | -$1.23 | -$1.34 | Miss -8.94% | $867.0K |
| May 4, 2023 | -$1.24 | -$1.38 | Miss -11.29% | $4.6M |
| Mar 1, 2023 | -$1.22 | -$1.45 | Miss -18.85% | $2.0M |
| Nov 3, 2022 | -$1.19 | -$1.28 | Miss -7.56% | $2.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026